1. CAR T-cells: costs, comparisons, and commentary. (3rd July 2019) Authors: Hay, Annette E.; Cheung, Matthew C. Journal: Journal of medical economics Issue: Volume 22:Number 7(2019) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis. Issue 11 (November 2014) Authors: Mozessohn, Lee; Cheung, Matthew C.; Crump, Michael; Buckstein, Rena; Berinstein, Neil; Imrie, Kevin; Kuruvilla, John; Piliotis, Eugenia; Kukreti, Vishal Journal: Leukemia & lymphoma Issue: Volume 55:Issue 11(2014:Nov.) Page Start: 2502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The impact of pricing strategy on the costs of oral anti‐cancer drugs. (27th May 2019) Authors: Truong, Judy; Chan, Kelvin K. W.; Mai, Helen; Chambers, Alexandra; Sabharwal, Mona; Trudeau, Maureen E.; Cheung, Matthew C. Journal: Cancer medicine Issue: Volume 8:Number 8(2019:Jul.) Page Start: 3770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cystic lung disease with kappa light chain deposition in newly diagnosed multiple myeloma. (17th October 2019) Authors: Clayden, Robert C.; Macdonald, Denis; Oikonomou, Anastasia; Cheung, Matthew C. Journal: British journal of haematology Issue: Volume 188:Number 2(2020) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies. Issue 1 (2nd January 2020) Authors: Cheung, Matthew C.; Croxford, Ruth; Earle, Craig C.; Singh, Simron Journal: Leukemia & lymphoma Issue: Volume 61:Issue 1(2020) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation. Issue 12 (15th October 2021) Authors: Mou, Eric; Falchi, Lorenzo; Sundaram, Vandana; Abramson, Jeremy S.; Balassanian, Ronald; Beygi, Sara; Fitzpatrick, Megan J.; Frank, Annabel Kate; Gupta, Srishti; Lin, Oscar; Reed, Joshua R.; Long, Steven R.; Ly, Amy; Menke, Joshua R.; Reed, Daniel R.; Ruiz-Cordero, Roberto; Volaric, Ashley K.; Xi... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 12(2021) Page Start: 2864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Examining the association between oncology drug clinical benefit and the time to public reimbursement. (1st December 2021) Authors: Thomson, Sasha; Everest, Louis; Witzke, Noah; Jiao, Tina; Delos Santos, Seanthel; Nguyen, Vivian; Cheung, Matthew C.; Chan, Kelvin K. W. Journal: Cancer medicine Issue: Volume 11:Number 2(2022) Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. COVID‐19 vaccine response in patients with hematologic malignancy: A systematic review and meta‐analysis. Issue 4 (13th January 2022) Authors: Gong, Inna Y.; Vijenthira, Abi; Betschel, Stephen D.; Hicks, Lisa K.; Cheung, Matthew C. Journal: American journal of hematology Issue: Volume 97:Issue 4(2022) Page Start: E132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast–Count Acute Myeloid Leukemia. Issue 4 (April 2021) Authors: Mozessohn, Lee; Cheung, Matthew C.; Mittmann, Nicole; Earle, Craig C.; Liu, Ning; Buckstein, Rena Journal: JCO oncology practice Issue: Volume 17:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Validation of the NCCN-IPI in both de novo and transformed diffuse large B cell lymphoma. Issue 1 (2nd January 2017) Authors: Spiegel, Jay Y.; Cheung, Matthew C.; Guirguis, Hany R.; Buckstein, Rena Journal: Leukemia & lymphoma Issue: Volume 58:Issue 1(2017) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗